Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_assertion evidence source_evidence_literature NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_assertion SIO_000772 18523305 NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_assertion wasDerivedFrom befree-20150227 NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_assertion wasGeneratedBy ECO_0000203 NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.